HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
about
sameAs
Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-AnalysisTargeting the Brain Reservoirs: Toward an HIV CureDescription and Demonstration of Cognitive Behavioral Therapy to Enhance Antiretroviral Therapy Adherence and Treat Depression in HIV-Infected Adults.Transcriptional Gene Silencing (TGS) via the RNAi Machinery in HIV-1 InfectionsTreatment interruption and variation in tablet taking behaviour result in viral failure: a case-control study from Cape Town, South Africa.Gender-specific risk factors for virologic failure in KwaZulu-Natal: automobile ownership and financial insecurity.Cost-effectiveness of a nurse-based intervention (AIMS) to improve adherence among HIV-infected patients: design of a multi-centre randomised controlled trialConceptual framework for behavioral and social science in HIV vaccine clinical research.Adherence with drug therapy in pregnancyMoving Beyond Directly Observed Therapy for Tuberculosis.A Social-Ecological View of Barriers and Facilitators for HIV Treatment Adherence: Interviews with Puerto Rican HIV Patients.Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV with Nonadherence to Antiretroviral Therapy.Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen.Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots.The Association Between Neighborhood Poverty and HIV Diagnoses Among Males and Females in New York City, 2010-2011.Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.Synthetic immunotherapy induces HIV virus specific Th1 cytotoxic response and death of an HIV-1 infected human cell line through classic complement activation.HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial.Developing a predictive risk model for first-line antiretroviral therapy failure in South AfricaAdherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis.Antiretroviral Refill Adherence Correlates with, But Poorly Predicts Retention in HIV Care.Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic.A qualitative study examining HIV antiretroviral adherence counseling and support in community pharmaciesRandomized clinical trial comparing the pharmacokinetics of standard- and increased-dosage lopinavir-ritonavir coformulation tablets in HIV-positive pregnant women.Examining the relationship between psychological distress and adherence to anti-retroviral therapy among Ugandan adolescents living with HIV.Adherence to combination antiretroviral treatment and clinical outcomes in a Medicaid sample of older HIV-infected adults.Use of Self-Reported Adherence and Keeping Clinic Appointments as Predictors of Viremia in Routine HIV Care in the Gambia.Intimate Partner Violence Against HIV-Positive Women is Associated with Sub-Optimal Infant Feeding Practices in Lusaka, Zambia.Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity.The effects of setarud on the immunological status of HIV-positive patients: Efficacy of a novel multi-herbal drug.HIV-Positive Women Taking Lifelong Antiretroviral Therapy Report Better Adherence Than Women Taking Short-Course Prophylaxis During and After Pregnancy Under PMTCT Program Option A in Lusaka, Zambia.Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.Higher Art Adherence is Associated with Lower Systemic Inflammation in Treatment-Naïve Ugandans Who Achieve Virologic Suppression.Prevalence and Factors Associated with Fixed-Dose Combination Antiretroviral Drugs Adherence among HIV-Positive Pregnant Women on Option B Treatment in Mpumalanga Province, South Africa.HIV-1 resistance rarely observed in patients using darunavir once-daily regimens across clinical studies.A week 48 randomized phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve HIV-1 patients.Cost-effectiveness of once-daily versus twice-daily regimens in the treatment of HIV infection in sub-Saharan Africa: a probabilistic decision model
P2860
Q26772247-DDA17775-220C-4751-9AE6-20EFAC2D27EBQ28075694-456EE996-8781-4B06-86E9-858314E68011Q30689502-6D815C79-370F-4A71-9FA1-2D6545C5904CQ33565167-5B30E5E1-1A65-4D4F-8BF7-A77199D781FAQ33999150-CFBB3DFF-D28F-4A39-B477-F0B0A20F1D26Q34345205-2441063A-C27A-44BF-BB0F-95A0F85C3FE4Q34995331-79655603-971E-40D3-B5E7-5CCEB82E537FQ35301155-9D831E71-8CF3-4B7D-96F5-3876DEEAEF18Q35660022-BEBBD9EC-DE39-4B25-A3B5-75F7058C1096Q35776285-F5D2D519-005D-4DC9-B880-D3CADA820889Q35793546-A310CF17-FEAF-4BC0-9931-D5C4A087B266Q35894827-053AF289-62AC-444B-9F17-AC280420797EQ35917578-2EE0AF52-5CC3-407B-996B-8D1AF43CF699Q36023047-0BB33892-E7A4-421F-9CFA-7DF02B474CACQ36554980-50773045-6224-4955-B856-4E1E5FB396C0Q36609638-0F0CDDE3-5075-467A-A353-21099AFC1118Q36614360-C26486D3-A9E1-4F2B-878C-DE5BD80B7458Q36669337-368B78AD-E9EC-444E-90DD-0463EEBE5514Q36766857-1895D267-B440-4121-BF66-5B1A8159AD95Q37238836-DD98A264-D26A-43BE-AF66-3C3E10C9DA24Q37290134-B2407BC1-D99B-457E-9B8A-786AEB00C285Q37335159-0FAA0C99-6859-48FC-9777-7ED1A0F85F52Q37344631-8B51D1A2-81E9-43D4-8558-5DCFA1C86F20Q37403995-150355D4-F4A0-4540-AD86-647B794A44CCQ37706020-84D571D4-679E-4593-B0DC-EB7964A0855AQ37712960-4D735E95-84CC-453B-89F2-254C4EAA2494Q38854250-828B6CC1-0216-4837-85E9-3E1766062119Q39148090-9D1BA917-938D-4108-B142-1C4834BE7ECAQ39351980-40D0FCBA-F7EF-4579-ABA3-13F529787EE5Q39568482-1BEA3CCD-2A9B-42A5-8D35-205E987F27CFQ39979692-C2C128AD-B4B5-418B-BFC6-075C96E6F5E6Q40117873-6083B6B0-7B21-4894-AA50-4A9B09282D6AQ41288663-BCA3C255-68C1-4E5D-8886-0335512A2E5FQ42256506-CFD8562B-4E3D-4DAB-946A-C142D312B41FQ42620819-1BAD5F32-F3B8-4ADF-B3CC-0962C685EF1EQ47551904-0FCA328F-6C56-4AC4-B3EB-0A90F57FE78DQ47555283-528C1CFB-83F7-4882-9C09-57A581694189Q47578500-13F9AB9A-7FF4-4440-81E1-631C3B7D0AAFQ52570173-1ABE0CF7-266F-4EB4-9E12-FE174E393D51Q57990836-101AD249-4F5B-4AFA-B6F6-E7292578870D
P2860
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
@ast
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
@en
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
@en-gb
HIV treatment adherence, drug resistance, virologic failure: evolving concepts
@nl
type
label
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
@ast
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
@en
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
@en-gb
HIV treatment adherence, drug resistance, virologic failure: evolving concepts
@nl
altLabel
HIV treatment adherence, drug resistance, virologic failure: evolving concepts
@en
prefLabel
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
@ast
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
@en
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
@en-gb
HIV treatment adherence, drug resistance, virologic failure: evolving concepts
@nl
P2093
P2860
P3181
P1476
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
@en
HIV treatment adherence, drug resistance, virologic failure: evolving concepts
@en
P2093
Edward J Mills
Edward J. Mills
Edward M Gardner
Edward M. Gardner
Gert U van Zyl
Gert U. van Zyl
Jean B Nachega
Jean B. Nachega
Robert Gross
Steven Y Hong
P2860
P3181
P356
10.2174/187152611795589663
P407
P577
2011-04-01T00:00:00Z